Arbutus Biopharma Corporation News
5 Top Stock Gainers for Wednesday; Dow Falls on Omicron Variant Fears
Box, Build-A-Bear-Workshop, Ambarella, Lennar and Arbutus Biopharma are five top stock gainers for Wednesday.
Anavex Higher on Phase 2 Progress With Parkinson's Drug
Anavex shares rose on reported clinical-trial progress with a Parkinson's drug candidate. JonesTrading analyst Soumit Roy raised his price target to $50.
Premarket Movers Monday: Intellia Therapeutics, Boeing, Nvidia
Stocks moving in premarket trading Monday include Intellia Therapeutics, Boeing, Nvidia, Arbutus Biopharma and NRG Energy.
Arbutus Higher After Report of Progress With Hepatitis B Drug
Data support continued evaluation of AB-729 'as the cornerstone of combination treatment' for Hepatitis B,' Arbutus Biopharma said.
Bally's Close to Making a Huge Las Vegas Strip Deal
The casino operator does not own the casino that carries its name, but changes are in the works.
New Coca-Cola Flavor is So Hip, It Comes With Its Own QR Code
Beverage giant is rolling out a new taste in its efforts to attract and keep a key demographic.
You'll Almost Have to Buy an Electric Vehicle if Climate Bill Passes
You can find savings on everything from EVs to solar panels in the Inflation Reduction Act.